A LAYTOWN family is racing against time to raise €2.7 million for life-changing treatment in the United States for their ...

In a letter to European patients, Roche said its decision to end development of “emugrobart” was based on the drug “not ...

Dr. Diana Castro (left) checks Hudson Sanford’s, a young boy with Duchenne muscular dystrophy traveling from Arizona, heartbeat before he is dosed with ELEVIDYS at the Neurology & Neuromuscular Care ...

Late-stage trial data for Roche’s drug against muscle-wasting Elevidys showed positive results after two years of treatment for male patients aged 4 or older with Duchenne muscular dystrophy. The data ...

People with spinal muscle atrophy (SMA), an inherited neuromuscular disease, usually experience muscle weakness that impacts movement. New research suggests that electrical spinal cord stimulation ...

Researchers discovered that R. inulinivorans plays an important role in muscle strength and could act as a probiotic candidate for nutraceutical interventions targeting age-related muscle-wasting ...

WASHINGTON (AP) — Three people with a muscle-destroying disease destined to worsen got a little stronger – able to stand and walk more easily – when an implanted device zapped their spinal cord. On ...

Distal spinal muscular atrophy (DSMA) is a rare genetic disease that causes a loss of muscle movement. It affects muscles further away from the center of the body, such as the hands, feet, and legs.

With the intensification of global population aging, muscle atrophy, characterized by the loss of muscle mass and function, has become an important health issue affecting the elderly. Researchers have ...